Abstract
l-Methionine-dl-sulfoxide (MetO) is an l-methionine (Met) metabolite, but its role in Met metabolism and toxicity is not clear. In this study, MetO uptake, metabolism to Met, cytotoxicity, and glutathione (GSH) and glutathione disulfide (GSSG) status were characterized in freshly isolated mouse hepatocytes incubated at 37°C with 0 to 30 mM MetO for 0 to 5 h. In male hepatocytes, dose-dependent cytotoxicity concomitant with GSH depletion without GSSG formation occurred after exposure to 20 or 30 mM MetO but not after exposure to 10 mM MetO. Interestingly, female hepatocytes exposed to 30 mM MetO showed no cytotoxicity and exhibited increased intracellular GSH levels compared with control hepatocytes. Male hepatocytes had approximately 2-fold higher levels of intracellular Met-d-O or Met-l-O after MetO (30 mM) exposure for 0 to 1.5 h compared with female hepatocytes. In hepatocytes of both genders, Met-l-O was detected at nearly 5-fold higher levels than Met-d-O, and no significant increase in cellular Met levels was detected. Addition of aminooxyacetic acid (AOAA), an inhibitor of transamination reactions, to MetO-exposed male hepatocytes resulted in higher cellular Met-d-O and Met-l-O levels and decreased the cytotoxicity of MetO. Interestingly, exposure of control male hepatocytes to AOAA selectively increased cellular Met-d-O levels to levels similar to those observed after exposure to MetO (30 mM). Analysis of MetO transamination activity by glutamine transaminase K in mouse liver cytosol revealed similar rates of MetO transamination in cytosol of both genders. Taken together, these results provide evidence for stereoselective oxidation of Met to Met-d-O under physiological conditions and suggest a major role for MetO transamination in MetO metabolism and toxicity.
Footnotes
-
This research is supported by National Institutes of Health Grants R01 DK044295 and T32-ES-007015.
-
doi:10.1124/dmd.108.023390.
-
ABBREVIATIONS: MetO, l-methionine-dl-sulfoxide; Met, l-methionine; FMO, flavin-containing monooxygenase; Met-d-O, l-methionine-d-sulfoxide; Met-l-O, l-methionine-l-sulfoxide; Msr, peptide methionine sulfoxide reductase; TB, trypan blue; LDH, lactate dehydrogenase; GSH, glutathione; GSSG, glutathione disulfide; HPLC, high-performance liquid chromatography; TA, transamination; AOAA, aminooxyacetic acid; GTK, glutamine transaminase K; SSA, 5-sulfosalicylic acid; PhP, phenylpyruvate; DMEM, Dulbecco's modified Eagle's medium; AUC, area under the curve.
- Received July 14, 2008.
- Accepted August 6, 2008.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|